Mirai 3D: Enhancing Surgical Precision with Biomodels and AR
Medicine has notably embraced this technology amid the growing shortage of supplies in various industries in Argentina; 3D printing technology emerges as a valuable resource for companies in different sectors. A pioneering company in this trend is Mirai 3D, which has revolutionized the medical industry with the creation of biomodels for surgery, combining 3D printing and augmented reality.
3D Printing in Medicine: Opening New Horizons
The pandemic that began in 2020 intensified collaboration between health and technology companies, leading to joint production of essential medical supplies. However, beyond meeting immediate needs, several companies have explored how 3D printing can transform medical practice.
Mirai 3D's value proposition is simple but revolutionary. The company specializes in the development of 3D models for simulation and surgical planning, a branch of "medical education." The process involves creating exact replicas of a patient's anatomy from MRI or CT scans through 3D printing. These "clones" allow surgeons to plan and practice procedures with precision before the operation.
What sets Mirai 3D apart is the combination of 3D printing with augmented reality (AR). Matías Biancucci, CEO and co-founder of Mirai 3D, explains that this fusion aims to minimize errors and doubts during surgical interventions. Augmented reality enhances the information provided by biomodels, offering a realistic simulation environment without significantly increasing costs.
A Detailed Look at Mirai 3D's Technology
Mirai 3D uses additive manufacturing techniques, including traditional 3D printing (such as FDM and SLA), silicone casting, and laser cutting. Additionally, they have developed Touchless 3D Navigation Technology (TNT), a motion tracking sensor that allows surgeons to manipulate the digital reconstruction of the patient's anatomy without physical contact during surgery.
This company has found applications in complex oncological surgeries, where precision in tumor location is critical. They also provide surgical planning services for congenital heart diseases, partial nephrectomies, lung cancer, and liver or pancreatic cancer. The company has also launched high-fidelity simulators for medical training, used in prostate, kidney, breast surgery, and more.
From Idea to Reality: The Mirai 3D Story
Mirai 3D had its beginnings in 2015 when the three co-founders were studying biomedical engineering at Favaloro University. The idea materialized in 2017, and since then, the company has experienced exceptional growth. In 2018, they won the Young Productive City Award and currently have a team of 10 professionals participating in more than 300 surgeries.
Mirai 3D's technology has transcended borders, reaching countries such as Mexico, Chile, Venezuela, Spain, the Netherlands, the United Kingdom, Qatar, and Pakistan. Their vision is to improve health through technological solutions, and in the long term, they aim to expand their range of simulation products, focusing on robotic surgery. Additionally, they plan to incorporate artificial intelligence and data analysis to guide surgeons in real-time during interventions.
Mirai 3D exemplifies the ability of 3D printing and augmented reality to transform medical practice. Their focus on precision, surgical planning, and medical training demonstrates how technology can improve the effectiveness of interventions and elevate standards in the healthcare industry. With a future that includes artificial intelligence and global expansion, Mirai 3D continues to lead the revolution in surgical training and precise planning.